81 related articles for article (PubMed ID: 17953817)
1. [Relationship between the CYP3A5 genetic polymorphism and susceptibility to and prognosis of childhood acute leukemia].
Huang Z; Chai YH; Cen JN
Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):546-8. PubMed ID: 17953817
[No Abstract] [Full Text] [Related]
2. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
[TBL] [Abstract][Full Text] [Related]
3. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
[TBL] [Abstract][Full Text] [Related]
4. The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia.
Sims RP
J Oncol Pharm Pract; 2016 Feb; 22(1):76-81. PubMed ID: 25305360
[TBL] [Abstract][Full Text] [Related]
5. CYP3A5 and NAT2 gene polymorphisms: role in childhood acute lymphoblastic leukemia risk and treatment outcome.
Silveira VS; Canalle R; Scrideli CA; Queiroz RG; Lopes LF; Tone LG
Mol Cell Biochem; 2012 May; 364(1-2):217-23. PubMed ID: 22215203
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia.
Lopes BA; Emerenciano M; Gonçalves BA; Vieira TM; Rossini A; Pombo-de-Oliveira MS
PLoS One; 2015; 10(5):e0127308. PubMed ID: 25992585
[TBL] [Abstract][Full Text] [Related]
7. CYP3A5 ∗ 3 genetic polymorphism is associated with childhood acute lymphoblastic leukemia risk: A meta-analysis.
Ma LM; Liu HC; Ruan LH; Feng YM
Biomed J; 2015; 38(5):428-32. PubMed ID: 25673168
[TBL] [Abstract][Full Text] [Related]
8. [Polymorphisms of CYP3A5 gene in acute leukemia patients and their role in chemotherapy and prognosis].
Shen LJ; Chen FY; Wang T; Wang HR; Zhong JH; Han JY; Ouyang RR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):26-30. PubMed ID: 18315894
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia.
Hartman A; van Schaik RH; van der Heiden IP; Broekhuis MJ; Meier M; den Boer ML; Pieters R
Leuk Res; 2010 Feb; 34(2):154-9. PubMed ID: 19467705
[TBL] [Abstract][Full Text] [Related]
10. Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility.
Berköz M; Yalin S
Leuk Res; 2009 Jul; 33(7):919-23. PubMed ID: 19144407
[TBL] [Abstract][Full Text] [Related]
11. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Lauten M; Asgedom G; Welte K; Schrappe M; Stanulla M
Haematologica; 2003 Mar; 88(3):353-4. PubMed ID: 12651279
[No Abstract] [Full Text] [Related]
12. Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children.
Damnjanovic T; Milicevic R; Novkovic T; Jovicic O; Bunjevacki V; Jekic B; Lukovic L; Novakovic I; Redzic D; Milasin J
J Pediatr Hematol Oncol; 2010 May; 32(4):e148-50. PubMed ID: 20445408
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic association with neurotoxicity in Hispanic children with acute lymphoblastic leukaemia.
McClain CA; Bernhardt MB; Berger A; Bernini JC; Marquez-Do D; Winslow R; Scheurer ME; Schafer ES
Br J Haematol; 2018 Jun; 181(5):684-687. PubMed ID: 28419449
[No Abstract] [Full Text] [Related]
14. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE).
Orsi L; Rudant J; Bonaventure A; Goujon-Bellec S; Corda E; Evans TJ; Petit A; Bertrand Y; Nelken B; Robert A; Michel G; Sirvent N; Chastagner P; Ducassou S; Rialland X; Hémon D; Milne E; Scott RJ; Baruchel A; Clavel J
Leukemia; 2012 Dec; 26(12):2561-4. PubMed ID: 22660188
[No Abstract] [Full Text] [Related]
15. [Association between CYP1A1*2A polymorphism and susceptibility to childhood acute lymphoblastic leukemia: a Meta analysis].
Zou ZQ; Yue LJ; Ren YF
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Oct; 17(10):1112-8. PubMed ID: 26483235
[TBL] [Abstract][Full Text] [Related]
16. Strengths and weaknesses of gene association studies in childhood acute lymphoblastic leukemia.
Semsei AF; Antal P; Szalai C
Leuk Res; 2010 Mar; 34(3):269-71. PubMed ID: 19716175
[No Abstract] [Full Text] [Related]
17. In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia.
Gézsi A; Lautner-Csorba O; Erdélyi DJ; Hullám G; Antal P; Semsei ÁF; Kutszegi N; Hegyi M; Csordás K; Kovács G; Szalai C
Pharmacogenomics J; 2015 Jun; 15(3):241-7. PubMed ID: 25266680
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of the thymidylate synthase gene and risk of relapse in childhood ALL.
Pietrzyk JJ; Bik-Multanowski M; Skoczen S; Kowalczyk J; Balwierz W; AlicjaChybicka ; Matysiak M; Szczepanski T; Balcerska A; Bodalski J; Krawczuk-Rybak M; Wysocki M; Sobol G; Wachowiak J
Leuk Res; 2011 Nov; 35(11):1464-6. PubMed ID: 21550658
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CYP3A5 mRNA in children with acute leukemia].
Huang Z; Chai YH; Cen JN; He HL; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):549-54. PubMed ID: 19650988
[TBL] [Abstract][Full Text] [Related]
20. Association study of cyclooxygenase 2 single nucleotide polymorphisms and childhood acute lymphoblastic leukemia in Taiwan.
Wang CH; Wu KH; Yang YL; Peng CT; Wang RF; Tsai CW; Tsai RY; Lin DT; Tsai FJ; Bau DT
Anticancer Res; 2010 Sep; 30(9):3649-53. PubMed ID: 20944149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
